Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First-line Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07383116
What this trial is testing

Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy as First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer

Who this might be right for
Non Squamous Non-small Cell Lung Cancer
Shanghai Huaota Biopharmaceutical Co., Ltd. 500
Not applicableActive Not RecruitingNCT07243288
What this trial is testing

Evaluation of an Early Radiomic Signature in Patients With Metastatic Pancreatic Adenocarcinoma Treated With First-line Chemotherapy

Who this might be right for
Pancreatic CancerMeSH Term-Pancreatic Cancer, Adult)
Assistance Publique - Hôpitaux de Paris 400
Testing effectiveness (Phase 2)Ended earlyNCT00404703
What this trial is testing

Avastin (Bevacizumab) in Combination With Platinum-Based Chemotherapy in Patients With Advanced or Recurrent Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 37
Large-scale testing (Phase 3)Study completedNCT01030042
What this trial is testing

Trial Comparing Two Two Sequences of Therapy in Colorectal Metastatic Patients

Who this might be right for
Metastatic Colorectal Cancer
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente 110
Testing effectiveness (Phase 2)Ended earlyNCT03317496
What this trial is testing

Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies

Who this might be right for
Non-small Cell Lung CancerUrothelial Cancer
Pfizer 67
Testing effectiveness (Phase 2)Study completedNCT02915523
What this trial is testing

Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerPeritoneal CancerFallopian Tube Cancer
Syndax Pharmaceuticals 140
Testing effectiveness (Phase 2)Study completedNCT00003731
What this trial is testing

Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 39
Early research (Phase 1)Study completedNCT00644124
What this trial is testing

Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Sanofi 25
Testing effectiveness (Phase 2)UnknownNCT03703596
What this trial is testing

Anlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLC

Who this might be right for
Lung CancerLung Cancer Metastatic
Sichuan Cancer Hospital and Research Institute 88
Testing effectiveness (Phase 2)Study completedNCT01138046
What this trial is testing

Phase I/II Study of Lapatinib in Combination With Paclitaxel as 1L Chemotherapy for ErbB2-positive MBC

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 12
Testing effectiveness (Phase 2)UnknownNCT04124731
What this trial is testing

Combination Therapy of Sintilimab and Anlotinib as a First-line Treatment in Advanced NSCLC (SUNRISE)

Who this might be right for
CarcinomaNon-small Cell Lung Cancer
Shanghai Chest Hospital 98
Large-scale testing (Phase 3)Active Not RecruitingNCT02516241
What this trial is testing

Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer

Who this might be right for
Urothelial Cancer
AstraZeneca 1,126
Large-scale testing (Phase 3)UnknownNCT05540951
What this trial is testing

VIC Regimen Versus Bevacizumab Plus Chemotherapy as First-Line Treatment for BRAF V600E-Mutated Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Fudan University 78
Testing effectiveness (Phase 2)WithdrawnNCT05383001
What this trial is testing

Randomized Phase II, Open-label Efficacy and Safety Study of Second-line Durvalumab Plus Tremelimumab Versus Platinum-based Chemotherapy Alone in Patients With NSCLC and First-line Checkpoint-inhibitor Therapy (Re-Check)

Who this might be right for
NSCLC Stage IV
AIO-Studien-gGmbH
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07062328
What this trial is testing

A Trial of Recaticimab and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable BTC

Who this might be right for
Biliary Tract Carcinoma
Sun Yat-sen University 39
Testing effectiveness (Phase 2)Looking for participantsNCT05460000
What this trial is testing

A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma+1 more
North Eastern German Society of Gynaecological Oncology 640
Large-scale testing (Phase 3)Study completedNCT03675737
What this trial is testing

Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)

Who this might be right for
Stomach Neoplasms
Merck Sharp & Dohme LLC 1,579
Testing effectiveness (Phase 2)Study completedNCT02899195
What this trial is testing

Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma

Who this might be right for
MesotheliomaPleural Mesothelioma
PrECOG, LLC. 55
Not applicableUnknownNCT04891900
What this trial is testing

TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric CancerAdenocarcinoma of Esophagogastric Junction
Henan Cancer Hospital 25
Not applicableActive Not RecruitingNCT04030507
What this trial is testing

Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast CancerTriple Negative Breast Cancer+3 more
Brigham and Women's Hospital 214
Next Page